Heparanase: One Molecule with Multiple Functions in Cancer Progression

REFERENCES

• Bernfield M., Gotte, Park M., Reizes P.W., Fitzgerald O., Lincecum M.L., Zako J. M. Annu. Rev. Biochem. 1999; 68: 729–777
   PubMed Web of Science ®Google Scholar
• Vlodavsky I., Miao H.Q., Medalion B., Danagher P., Ron D. Involvement of heparan sulfate and related molecules in sequestration and growth promoting activity of fibroblast growth factor. Cancer Metastasis Rev. 1996; 15: 177–186
   PubMed Web of Science ®Google Scholar
• Dempsey L.A., Brunn G.J., Platt J.L. Heparanase, a potential regulator of cell-matrix interactions. Trends Biochem. Sci. 2000; 25: 349–351
   PubMed Web of Science ®Google Scholar
• Vlodavsky I., Friedmann Y. Molecular properties and involvement of heparanase in cancer metastasis and angiogenesis. J. Clin. Invest. 2001; 108: 341–347
   PubMed Web of Science ®Google Scholar
• Parish C.R., Freeman C., Hulett M.D. Heparanase: a key enzyme involved in cell invasion. Biochim. Biophys. Acta 2001; 1471: M99–108
   PubMed Web of Science ®Google Scholar
• Ilan N., Elkin M., Vlodavsky I. Regulation, function and clinical significance of heparanase in cancer metastasis and angiogenesis. Int. J. Biochem. Cell Biol. 2006; 38: 2018–2039
   PubMed Web of Science ®Google Scholar
• Vreys V., David G. Mammalian heparanase: what is the message?. J. Cell. Mol. Med. 2004; 11: 427–452
   Web of Science ®Google Scholar
• McKenzie E.A. Heparanase: a target for drug discovery in cancer and inflammation. Br. J. Pharmacol. 2007; 151: 1–14
   PubMed Web of Science ®Google Scholar
• Sanderson R.D., Yang Y., Suva L.J., Kelly T. Heparan sulfate proteoglycans and heparanase—partners in osteolytic tumor growth and metastasis. Matrix Biol. 2004; 23: 341–352
   PubMed Web of Science ®Google Scholar
• van den Hoven, M.J., Rops A.L., Vlodavsky I., Levidiotis V., Berden J.H., van der Vlag J. Heparanase in glomerular diseases. Kidney Int. 2007; 72: 543–548
   PubMed Web of Science ®Google Scholar
• Nardella C., Lahm A., Pallaoro M., Brunetti M., Vannini A., Steinkuhler C. Mechanism of activation of human heparanase investigated by protein engineering. Biochemistry. 2004; 43: 1862–1873
   PubMed Web of Science ®Google Scholar
• Abboud-Jarrous G., Rangini-Guetta Z., Aingorn H., Atzmon R., Elgavish S., Peretz T., Vlodavsky I. Site-directed mutagenesis, proteolytic cleavage, and activation of human proheparanase. J. Biol. Chem. 2005; 280: 13568–13575
   PubMed Web of Science ®Google Scholar
• Nakajima M., Irimura T., Nicolson G.L. Heparanases and tumor metastasis. J. Cell. Biochem. 1988; 36: 157–167
   PubMed Web of Science ®Google Scholar
• Takaoka M., Naomoto Y., Ohkawa T., Uetsuka H., Shirakawa Y., Uno F., Fujiwara T., Gunduz M., Nagatsuka H., Nakajima M., Tanaka N., Haisa M. Heparanase expression correlates with invasion and poor prognosis in gastric cancers. Lab. Invest. 2003; 83: 613–622
   PubMed Web of Science ®Google Scholar
• Shafat I., Zcharia, Nisman E., Nadir B., Nakhoul Y., Vlodavsky F., Ilan I., Ilan N. An ELISA method for the detection and quantification of human heparanase. Biochem. Biophys. Res. Commun. 2006; 341: 958–963
   PubMed Web of Science ®Google Scholar
• Shafat I., Ben Break, Postovsky A., Elhasid S., Ilan R. N., Vlodavsky, I., and Weyl Ben Arush, M., Heparanase levels are elevated in the plasma of pediatric cancer patients and correlate with response to anticancer treatment. Neoplasia 2006; 9: 909–916
   Web of Science ®Google Scholar
• Joyce J.A., Freeman C., Meyer-Morse N., Parish C.R., Hanahan D. A functional heparan sulfate mimetic implicates both heparanase and heparan sulfate in tumor angiogenesis and invasion in a mouse model of multistage cancer. Oncogene 2005; 24: 4037–4051
   PubMed Web of Science ®Google Scholar
• Zetser A., Bashenko Y., Edovitsky E., Levy-Adam F., Vlodavsky I., Ilan N. Heparanase induces vascular endothelial growth factor expression: correlation with p38 phosphorylation levels and Src activation. Cancer Res. 2006; 66: 1455–1463
   PubMed Web of Science ®Google Scholar
• Ben-Zaken O., Gingis-Velitski S., Vlodavsky I., Ilan N. Heparanase induces Akt phosphorylation via a lipid raft receptor. Biochem. Biophys. Res. Commun. 2007; 361: 829–834
   PubMed Web of Science ®Google Scholar
• Vlodavsky I., Ilan N., Naggi A., Casu B. Heparanase: structure, biological functions, and inhibition by heparin-derived mimetics of heparan sulfate. Curr. Pharm. Des. 2007; 13: 2057–2073
   PubMed Web of Science ®Google Scholar
• Ferro V., Hammond E., Fairweather J.K. The development of inhibitors of heparanase, a key enzyme involved in tumour metastasis, angiogenesis and inflammation. Mini. Rev. Med. Chem. 2004; 4: 693–702
   PubMed Web of Science ®Google Scholar
• Simizu S., Ishida K., Osada H. Heparanase as a molecular target of cancer chemotherapy. Cancer Sci. 2004; 95: 553–558
   PubMed Web of Science ®Google Scholar
• Li J-P., Escobar M.L., Gong F., Zhang X., Zcharia E., Kisilevsky R., Vlodavsky I., Lindahl U. Over-expression of human heparanase renders mice resistant to inflammation-associated amyloidosis. Proc. Natl. Acad. Sci. USA. 2005; 102: 6473–6477
   PubMed Web of Science ®Google Scholar